MRBEV
Measles & Rubella
CommercialActive
Key Facts
About Biological E.
Indian vaccine maker Biological E leverages recombinant and conjugate platforms to supply a broad infectious‑disease portfolio across emerging markets.
View full company profileMeasles & Rubella
Indian vaccine maker Biological E leverages recombinant and conjugate platforms to supply a broad infectious‑disease portfolio across emerging markets.
View full company profile